Re-purposing current drugs to treat COVID-19
- Funded by UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: C19-IUC-222
Grant search
Key facts
Disease
COVID-19Funder
UK Research and Innovation (UKRI)Principal Investigator
Karim LabibResearch Location
United KingdomLead Research Institution
MRC Protein Phosphorylation and Ubiquitylation Unit at the University of DundeeResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
We are developing tests to find out whether existing drugs could quickly be repurposed to treat COVID 19. As part of a collaboration with the Francis Crick institute in London, we are developing tests for drugs that might inhibit two of the enzymes of the SARS-CoV-2 virus: one called Nsp15 (an RNase) and another called Nsp14 (a methyltransferase)